Income Statement Universal Health Services, Inc.

Equities

UHS

US9139031002

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 02:30:02 07/03/2026 am IST			5-day change	1st Jan Change
192.65 ^USD	-2.19%		-6.53%	-11.64%

03/03	Universal Health Services, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 11:50 AM
03/03	Goldman Sachs Adjusts Universal Health Services PT to $242 From $236, Maintains Neutral Rating	MT

0b93fa6f7f.yT3pvPdGi5nPT1mvrxUc6lqXqD8rJJ4zQDv4msi4vWU.pA6KiYMRs--hDS369XYqmwqj6nhMdcQAFFm33_3W5zqNC9zOpTO_36YrMg

Published financial data: UNIVERSAL HEALTH SERVICES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.26TCr	1.34TCr	1.43TCr	1.58TCr	1.74TCr
Total Revenues	1.26TCr	1.34TCr	1.43TCr	1.58TCr	1.74TCr
Cost of Goods Sold, Total	759.11Cr	823.66Cr	864.03Cr	910.65Cr	974.36Cr
Gross Profit	505.1Cr	516.28Cr	564.17Cr	672.15Cr	762.12Cr
Selling General & Admin Expenses, Total	12Cr	13Cr	14Cr	15Cr	15Cr
Depreciation & Amortization - (IS)	53Cr	58Cr	57Cr	58Cr	62Cr
Other Operating Expenses	300.46Cr	338.82Cr	375.72Cr	430.84Cr	486.02Cr
Other Operating Expenses, Total	365.67Cr	410.17Cr	446.63Cr	503.96Cr	562.72Cr
Operating Income	139.43Cr	106.11Cr	117.54Cr	168.18Cr	199.4Cr
Interest Expense, Total	-8.53Cr	-13Cr	-21Cr	-19Cr	-16Cr
Interest And Investment Income	32.96L	21.78L	24.72L	33.25L	25.89L
Net Interest Expenses	-8.2Cr	-13Cr	-20Cr	-18Cr	-15Cr
Income (Loss) On Equity Invest.	62L	12L	9L	11L	10L
Other Non Operating Income (Expenses)	59.91L	-1.34Cr	-3.11Cr	-8L	13Cr
EBT, Excl. Unusual Items	132.45Cr	92Cr	94Cr	149.79Cr	197.21Cr
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Asset Writedown	-1.44Cr	-5.76Cr	-	-	-
Other Unusual Items	-1.68Cr	-	-	-	-
EBT, Incl. Unusual Items	129.33Cr	87Cr	94Cr	149.79Cr	197.21Cr
Income Tax Expense	31Cr	21Cr	22Cr	33Cr	46Cr
Earnings From Continuing Operations	99Cr	66Cr	72Cr	116.31Cr	151.12Cr
Net Income to Company	99Cr	66Cr	72Cr	116.31Cr	151.12Cr
Minority Interest	39.58L	1.86Cr	-15.12L	-2.1Cr	-2.24Cr
Net Income - (IS)	99Cr	68Cr	72Cr	114.21Cr	148.88Cr
Preferred Dividend and Other Adjustments	20.59L	7L	3L	50T	-
Net Income to Common Incl Extra Items	99Cr	67Cr	72Cr	114.2Cr	148.88Cr
Net Income to Common Excl. Extra Items	99Cr	67Cr	72Cr	114.2Cr	148.88Cr
Per Share Items
Net EPS - Basic	11.99	9.23	10.35	17.16	23.42
Basic EPS - Continuing Operations	11.99	9.23	10.35	17.16	23.42
Basic Weighted Average Shares Outstanding	8.25Cr	7.31Cr	6.93Cr	6.66Cr	6.36Cr
Net EPS - Diluted	11.82	9.14	10.23	16.82	23.1
Diluted EPS - Continuing Operations	11.82	9.14	10.23	16.82	23.1
Diluted Weighted Average Shares Outstanding	8.37Cr	7.38Cr	7.01Cr	6.79Cr	6.45Cr
Normalized Basic EPS	10.08	8.15	8.46	13.75	19.03
Normalized Diluted EPS	9.94	8.07	8.36	13.48	18.77
Dividend Per Share	0.8	0.8	0.8	0.8	0.8
Payout Ratio	6.65	8.65	7.73	4.67	3.44
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	192.75Cr	164.3Cr	174.34Cr	226.66Cr	261.28Cr
EBITA	139.43Cr	106.11Cr	117.54Cr	168.18Cr	199.4Cr
EBIT	139.43Cr	106.11Cr	117.54Cr	168.18Cr	199.4Cr
EBITDAR	204.64Cr	177.46Cr	188.44Cr	241.31Cr	276.1Cr
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	23.64	24.16	23.51	22.35	23.37
Current Domestic Taxes	32Cr	21Cr	23Cr	36Cr	39Cr
Current Foreign Taxes	1.38Cr	1.47Cr	65.05L	1.1Cr	1.56Cr
Total Current Taxes	34Cr	23Cr	24Cr	37Cr	41Cr
Deferred Domestic Taxes	-3.11Cr	-1.6Cr	-2.13Cr	-3.21Cr	4.47Cr
Deferred Foreign Taxes	15.21L	-15.09L	33.67L	-13.18L	60.18L
Total Deferred Taxes	-2.95Cr	-1.76Cr	-1.8Cr	-3.35Cr	5.07Cr
Normalized Net Income	83Cr	60Cr	59Cr	92Cr	121.02Cr
Interest Capitalized	44.11L	86L	2.44Cr	3.89Cr	3.36Cr
Interest on Long-Term Debt	8.97Cr	14Cr	23Cr	23Cr	19Cr
Non-Cash Pension Expense	-19.97L	-14.99L	-77T	-4L	-29T
Supplemental Operating Expense Items
Net Rental Expense, Total	12Cr	13Cr	14Cr	15Cr	15Cr
Imputed Operating Lease Interest Expense	1.95Cr	2.91Cr	4.91Cr	5.14Cr	4.47Cr
Imputed Operating Lease Depreciation	9.94Cr	10Cr	9.19Cr	9.5Cr	10Cr
Stock-Based Comp., Other (Total)	7.37Cr	8.53Cr	8.77Cr	9.93Cr	9.57Cr
Total Stock-Based Compensation	7.37Cr	8.53Cr	8.77Cr	9.93Cr	9.57Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	12Cr	10Cr	12Cr	13Cr	14Cr
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	12Cr	10Cr	12Cr	13Cr	14Cr
Accounts Receivable, Total	174.66Cr	201.77Cr	223.83Cr	217.78Cr	260.24Cr
Total Receivables	174.66Cr	201.77Cr	223.83Cr	217.78Cr	260.24Cr
Inventory	21Cr	22Cr	22Cr	22Cr	23Cr
Other Current Assets, Total	19Cr	20Cr	24Cr	29Cr	44Cr
Total Current Assets	226.36Cr	253.73Cr	281.14Cr	281.63Cr	340.79Cr
Gross Property Plant And Equipment	1.11TCr	1.15TCr	1.22TCr	1.31TCr	1.39TCr
Accumulated Depreciation	-489.64Cr	-516.74Cr	-565.25Cr	-607.11Cr	-648.17Cr
Net Property Plant And Equipment	624.18Cr	637.31Cr	655.85Cr	699.09Cr	738.23Cr
Long-term Investments	18Cr	20Cr	17Cr	17Cr	27Cr
Goodwill	396.26Cr	390.95Cr	393.24Cr	393.29Cr	399.02Cr
Other Intangibles, Total	8.1Cr	7.81Cr	7.7Cr	7.63Cr	7.59Cr
Deferred Tax Assets Long-Term	4.57Cr	6.84Cr	8.56Cr	12Cr	7.05Cr
Deferred Charges Long-Term	65.25L	62.64L	69.74L	94.04L	92.72L
Other Long-Term Assets, Total	31Cr	32Cr	33Cr	35Cr	32Cr
Total Assets	1.31TCr	1.35TCr	1.4TCr	1.45TCr	1.55TCr
Liabilities
Accounts Payable, Total	66Cr	64Cr	61Cr	63Cr	75Cr
Accrued Expenses, Total	120.16Cr	112.16Cr	119.18Cr	144.95Cr	166.61Cr
Current Portion of Long-Term Debt	4.57Cr	7.84Cr	12Cr	3.48Cr	74Cr
Current Portion of Leases	6.72Cr	7.08Cr	7.46Cr	7.99Cr	7.9Cr
Current Income Taxes Payable	1.07Cr	46.08L	20.46L	1.42Cr	19.3L
Other Current Liabilities	6T	23.97L	72.86L	-	-
Total Current Liabilities	198.41Cr	191.44Cr	201.33Cr	221.04Cr	323.96Cr
Long-Term Debt	406.53Cr	465.4Cr	471.61Cr	437.72Cr	391.9Cr
Long-Term Leases	38Cr	47Cr	45Cr	46Cr	43Cr
Pension & Other Post Retirement Benefits	2Cr	1.9Cr	2.2Cr	2.3Cr	2.5Cr
Deferred Tax Liability Non Current	-	-	-	-	56.49L
Other Non Current Liabilities	44Cr	47Cr	56Cr	63Cr	50Cr
Total Liabilities	689.54Cr	752.41Cr	776.57Cr	770.69Cr	811.82Cr
Common Stock, Total	8L	7L	7L	6L	6L
Retained Earnings	605.86Cr	592.95Cr	613.9Cr	665.84Cr	722.74Cr
Comprehensive Income and Other	3.03Cr	-96.68L	92.89L	72.01L	4.78Cr
Total Common Equity	608.97Cr	592.06Cr	614.9Cr	666.62Cr	727.58Cr
Minority Interest	11Cr	4.95Cr	5.29Cr	9.66Cr	13Cr
Total Equity	619.82Cr	597Cr	620.19Cr	676.28Cr	740.94Cr
Total Liabilities And Equity	1.31TCr	1.35TCr	1.4TCr	1.45TCr	1.55TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	7.48Cr	7.07Cr	6.72Cr	6.5Cr	6.11Cr
ECS Total Common Shares Outstanding	7.71Cr	7.06Cr	6.72Cr	6.5Cr	6.11Cr
Book Value / Share	78.99	83.83	91.53	102.59	119.15
Tangible Book Value	204.6Cr	193.3Cr	213.96Cr	265.71Cr	320.97Cr
Tangible Book Value Per Share	26.54	27.37	31.85	40.89	52.56
Total Debt	455.94Cr	527.13Cr	536.66Cr	495.54Cr	516.65Cr
Net Debt	444.41Cr	516.85Cr	524.72Cr	482.94Cr	502.87Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	-1.13Cr	-93.5L	-1.28Cr	-1.5Cr	-1.74Cr
Debt Equivalent Oper. Leases	95Cr	105.3Cr	112.82Cr	117.15Cr	118.59Cr
Minority Interest, Total (Incl. Fin. Div)	11Cr	4.95Cr	5.29Cr	9.66Cr	13Cr
Equity Method Investments, Total	94L	84L	70L	58L	44L
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Others	21Cr	22Cr	22Cr	22Cr	23Cr
Land - (BS)	73Cr	73Cr	74Cr	75Cr	76Cr
Buildings, Total	650.96Cr	675.62Cr	714Cr	767.12Cr	807.63Cr
Machinery, Total	275.99Cr	293.7Cr	306.63Cr	326.04Cr	339.37Cr
Full Time Employees	68.3T	71.2T	73.35T	76T	78.4T
Part Time Employees	21.1T	22.6T	23.35T	23T	23.1T
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	99Cr	68Cr	72Cr	114.21Cr	148.88Cr
Depreciation & Amortization - CF	53Cr	58Cr	57Cr	58Cr	62Cr
Depreciation & Amortization, Total	53Cr	58Cr	57Cr	58Cr	62Cr
(Gain) Loss From Sale Of Asset	-51.7L	6L	-62.5L	-99.2L	79.68L
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-9.33Cr
Asset Writedown & Restructuring Costs	1.44Cr	5.76Cr	-	-	-
Stock-Based Compensation (CF)	7.37Cr	8.54Cr	8.77Cr	9.93Cr	9.57Cr
Other Operating Activities, Total	1.29Cr	-1.86Cr	15.12L	2.42Cr	2.24Cr
Change In Accounts Receivable	-88.73L	-26Cr	-18Cr	6.74Cr	-32Cr
Change In Income Taxes	-5.4Cr	-2.95Cr	-4.34Cr	1.27Cr	-2.14Cr
Change in Other Net Operating Assets	-67Cr	-9.85Cr	12Cr	15Cr	6.35Cr
Cash from Operations	88Cr	100Cr	126.78Cr	206.71Cr	186.44Cr
Capital Expenditure	-86Cr	-73Cr	-74Cr	-94Cr	-101.52Cr
Sale of Property, Plant, and Equipment	2.54Cr	1.2Cr	2.42Cr	3.86Cr	1.59Cr
Cash Acquisitions	-11Cr	-2.03Cr	-37.28L	-1.9Cr	-4.78Cr
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	1.97Cr	-	-	-	-2.47Cr
Investment in Marketable and Equity Securities, Total	-	-	-	-	5.32Cr
Other Investing Activities, Total	14.57L	9.5Cr	-4.07Cr	1.31Cr	-5.21Cr
Cash from Investing	-91Cr	-65Cr	-76Cr	-91Cr	-107.06Cr
Long-Term Debt Issued, Total	325.5Cr	71Cr	19Cr	221.02Cr	29Cr
Total Debt Issued	325.5Cr	71Cr	19Cr	221.02Cr	29Cr
Long-Term Debt Repaid, Total	-303.79Cr	-8.94Cr	-8.55Cr	-264Cr	-4.35Cr
Total Debt Repaid	-303.79Cr	-8.94Cr	-8.55Cr	-264Cr	-4.35Cr
Issuance of Common Stock	1.34Cr	1.41Cr	1.37Cr	1.51Cr	1.67Cr
Repurchase of Common Stock	-122.09Cr	-83Cr	-55Cr	-67Cr	-97Cr
Common Dividends Paid	-6.59Cr	-5.84Cr	-5.55Cr	-5.33Cr	-5.13Cr
Common & Preferred Stock Dividends Paid	-6.59Cr	-5.84Cr	-5.55Cr	-5.33Cr	-5.13Cr
Other Financing Activities, Total	-1.27Cr	-5.71Cr	-43.76L	-60.94L	1.07Cr
Cash from Financing	-106.9Cr	-32Cr	-49Cr	-114.49Cr	-75Cr
Foreign Exchange Rate Adjustments	-5L	-84.24L	30.56L	-8L	25.17L
Net Change in Cash	-110.02Cr	2.19Cr	1.36Cr	1.03Cr	4.66Cr
Supplemental Items
Cash Interest Paid	7.56Cr	12Cr	20Cr	17Cr	16Cr
Cash Income Tax Paid (Refund)	36Cr	25Cr	26Cr	33Cr	47Cr
Levered Free Cash Flow	28Cr	12Cr	31Cr	96Cr	57Cr
Unlevered Free Cash Flow	33Cr	20Cr	44Cr	107.37Cr	66Cr
Change In Net Working Capital	31Cr	39Cr	21Cr	-28Cr	26Cr
Net Debt Issued / Repaid	22Cr	62Cr	9.96Cr	-43Cr	24Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.56	4.99	5.35	7.39	8.31
Return on Total Capital	8.16	6.03	6.44	9.03	10.26
Return On Equity %	15.67	10.8	11.82	17.94	21.33
Return on Common Equity	15.95	11.24	11.89	17.82	21.36
Margin Analysis
Gross Profit Margin %	39.95	38.53	39.5	42.47	43.89
SG&A Margin	0.94	0.98	0.99	0.93	0.85
EBITDA Margin %	15.25	12.26	12.21	14.32	15.05
EBITA Margin %	11.03	7.92	8.23	10.63	11.48
EBIT Margin %	11.03	7.92	8.23	10.63	11.48
Income From Continuing Operations Margin %	7.81	4.9	5.04	7.35	8.7
Net Income Margin %	7.84	5.04	5.03	7.22	8.57
Net Avail. For Common Margin %	7.83	5.04	5.02	7.22	8.57
Normalized Net Income Margin	6.58	4.45	4.1	5.78	6.97
Levered Free Cash Flow Margin	2.22	0.93	2.17	6.04	3.26
Unlevered Free Cash Flow Margin	2.64	1.52	3.08	6.78	3.82
Asset Turnover
Asset Turnover	0.95	1.01	1.04	1.11	1.16
Fixed Assets Turnover	2.12	2.12	2.21	2.34	2.42
Receivables Turnover (Average Receivables)	7.27	7.12	6.71	7.17	7.27
Inventory Turnover (Average Inventory)	38.22	38.73	39.68	41.59	43.01
Short Term Liquidity
Current Ratio	1.14	1.33	1.4	1.27	1.05
Quick Ratio	0.94	1.11	1.17	1.04	0.85
Operating Cash Flow to Current Liabilities	0.45	0.52	0.63	0.94	0.58
Days Sales Outstanding (Average Receivables)	50.17	51.27	54.38	51.06	50.24
Days Outstanding Inventory (Average Inventory)	9.55	9.42	9.2	8.8	8.49
Average Days Payable Outstanding	29.49	28.66	26.42	25.03	25.86
Cash Conversion Cycle (Average Days)	30.23	32.03	37.16	34.83	32.87
Long Term Solvency
Total Debt/Equity	73.56	88.3	86.53	73.27	69.73
Total Debt / Total Capital	42.38	46.89	46.39	42.29	41.08
LT Debt/Equity	71.74	85.8	83.33	71.58	58.64
Long-Term Debt / Total Capital	41.33	45.56	44.68	41.31	34.55
Total Liabilities / Total Assets	52.66	55.76	55.6	53.26	52.28
EBIT / Interest Expense	16.35	8.34	5.67	8.97	12.68
EBITDA / Interest Expense	24	13.94	9.09	12.87	17.56
(EBITDA - Capex) / Interest Expense	13.96	8.18	5.51	7.83	11.1
Total Debt / EBITDA	2.23	2.97	2.85	2.05	1.87
Net Debt / EBITDA	2.17	2.91	2.78	2	1.82
Total Debt / (EBITDA - Capex)	3.83	5.07	4.7	3.37	2.96
Net Debt / (EBITDA - Capex)	3.73	4.97	4.6	3.29	2.88
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	9.37	5.99	6.59	10.82	9.71
Gross Profit, 1 Yr. Growth %	8.45	2.21	9.28	19.14	13.39
EBITDA, 1 Yr. Growth %	3.08	-14.76	6.11	30.01	15.27
EBITA, 1 Yr. Growth %	2.57	-23.9	10.77	43.09	18.56
EBIT, 1 Yr. Growth %	2.57	-23.9	10.77	43.09	18.56
Earnings From Cont. Operations, 1 Yr. Growth %	3.66	-33.48	9.49	61.7	29.93
Net Income, 1 Yr. Growth %	5.05	-31.87	6.24	59.11	30.36
Normalized Net Income, 1 Yr. Growth %	7.42	-28.35	-1.64	56.11	32.23
Diluted EPS Before Extra, 1 Yr. Growth %	7.55	-22.67	11.93	64.42	37.34
Accounts Receivable, 1 Yr. Growth %	1.02	15.52	10.93	-2.7	19.5
Inventory, 1 Yr. Growth %	8.62	5.65	-0.7	1.82	5.06
Net Property, Plant and Equip., 1 Yr. Growth %	9.32	2.1	2.91	6.59	5.6
Total Assets, 1 Yr. Growth %	-2.84	3.06	3.51	3.6	7.31
Tangible Book Value, 1 Yr. Growth %	-13	-5.52	10.69	24.19	20.8
Common Equity, 1 Yr. Growth %	-3.6	-2.78	3.86	8.41	9.14
Cash From Operations, 1 Yr. Growth %	-62.56	12.71	27.29	63.05	-9.81
Capital Expenditures, 1 Yr. Growth %	17	-14.22	1.23	27.02	7.56
Levered Free Cash Flow, 1 Yr. Growth %	-74.31	-55.56	149.01	208.3	-40.91
Unlevered Free Cash Flow, 1 Yr. Growth %	-71.22	-38.82	115.44	144.15	-38.2
Dividend Per Share, 1 Yr. Growth %	300	0	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.41	7.67	6.29	8.68	10.27
Gross Profit, 2 Yr. CAGR %	5.5	5.28	5.68	14.1	16.23
EBITDA, 2 Yr. CAGR %	3.37	-6.27	-4.9	17.46	22.42
EBITA, 2 Yr. CAGR %	3.03	-11.66	-8.19	25.9	30.25
EBIT, 2 Yr. CAGR %	3.03	-11.66	-8.19	25.9	30.25
Earnings From Cont. Operations, 2 Yr. CAGR %	9.25	-16.96	-14.66	33.06	44.94
Net Income, 2 Yr. CAGR %	10.31	-15.4	-14.92	30.02	44.02
Normalized Net Income, 2 Yr. CAGR %	7.87	-12.28	-16.05	23.92	43.68
Diluted EPS Before Extra, 2 Yr. CAGR %	13.78	-8.8	-6.97	35.66	50.27
Accounts Receivable, 2 Yr. CAGR %	5.78	8.03	13.2	3.89	7.83
Inventory, 2 Yr. CAGR %	13.74	7.12	2.42	0.55	3.43
Net Property, Plant and Equip., 2 Yr. CAGR %	8.08	5.65	2.51	4.74	6.1
Total Assets, 2 Yr. CAGR %	5.93	0.06	3.28	3.55	5.44
Tangible Book Value, 2 Yr. CAGR %	14.87	-9.34	2.26	17.24	22.48
Common Equity, 2 Yr. CAGR %	5.18	-3.19	0.49	6.11	8.78
Cash From Operations, 2 Yr. CAGR %	-21.62	-35.04	19.78	44.06	21.27
Capital Expenditures, 2 Yr. CAGR %	16.16	0.18	-6.81	13.4	16.88
Levered Free Cash Flow, 2 Yr. CAGR %	-33.39	-66.24	5.04	176.81	34.9
Unlevered Free Cash Flow, 2 Yr. CAGR %	-32.56	-58.04	14.83	129.34	22.83
Dividend Per Share, 2 Yr. CAGR %	15.47	100	0	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.48	5.6	7.31	7.78	9.03
Gross Profit, 3 Yr. CAGR %	5.11	4.39	6.6	9.99	13.86
EBITDA, 3 Yr. CAGR %	4.65	-3.07	-2.31	5.55	16.72
EBITA, 3 Yr. CAGR %	4.31	-6.87	-4.74	6.45	23.4
EBIT, 3 Yr. CAGR %	4.31	-6.87	-4.74	6.45	23.4
Earnings From Cont. Operations, 3 Yr. CAGR %	7.37	-7.4	-8.94	5.6	32
Net Income, 3 Yr. CAGR %	8.34	-6.06	-8.73	4.82	30.13
Normalized Net Income, 3 Yr. CAGR %	7.92	-5.88	-8.87	3.24	26.63
Diluted EPS Before Extra, 3 Yr. CAGR %	12.46	0.04	-2.36	12.48	36.21
Accounts Receivable, 3 Yr. CAGR %	5.07	8.93	8.99	7.63	8.85
Inventory, 3 Yr. CAGR %	11.75	10.97	4.45	2.22	2.03
Net Property, Plant and Equip., 3 Yr. CAGR %	8.79	6.05	4.73	3.85	5.02
Total Assets, 3 Yr. CAGR %	5.14	4.97	1.2	3.39	4.79
Tangible Book Value, 3 Yr. CAGR %	10.29	7.62	-3.1	9.1	18.42
Common Equity, 3 Yr. CAGR %	4.16	2.46	-0.9	3.06	7.11
Cash From Operations, 3 Yr. CAGR %	-11.5	-11.53	-18.71	32.75	23.24
Capital Expenditures, 3 Yr. CAGR %	8.77	5	0.53	3.32	11.42
Levered Free Cash Flow, 3 Yr. CAGR %	-15.37	-41.8	-34.27	50.39	65.44
Unlevered Free Cash Flow, 3 Yr. CAGR %	-15.87	-34.71	-27.61	47.66	48.13
Dividend Per Share, 3 Yr. CAGR %	25.99	10.06	58.74	0	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.3	5.18	5.8	6.82	8.48
Gross Profit, 5 Yr. CAGR %	4.01	3.61	5.34	8.17	10.35
EBITDA, 5 Yr. CAGR %	2.57	-1	0.72	4.67	6.92
EBITA, 5 Yr. CAGR %	1.7	-3.68	-0.88	5.07	7.96
EBIT, 5 Yr. CAGR %	1.7	-3.68	-0.88	5.07	7.96
Earnings From Cont. Operations, 5 Yr. CAGR %	5.74	-3.16	-2.05	7.04	9.66
Net Income, 5 Yr. CAGR %	7.14	-2.13	-1.64	6.99	9.54
Normalized Net Income, 5 Yr. CAGR %	4.17	-2.9	-2.39	5.07	9.34
Diluted EPS Before Extra, 5 Yr. CAGR %	10.61	3.2	4.24	13	16.02
Accounts Receivable, 5 Yr. CAGR %	3.94	6.15	8.25	6.89	8.52
Inventory, 5 Yr. CAGR %	10.53	9.92	7.92	6.68	4.04
Net Property, Plant and Equip., 5 Yr. CAGR %	7.58	6.87	6.23	5.52	5.27
Total Assets, 5 Yr. CAGR %	4.88	4.63	4.39	4.4	2.87
Tangible Book Value, 5 Yr. CAGR %	31.46	15.4	7.01	11.37	6.42
Common Equity, 5 Yr. CAGR %	6.08	3.48	2.67	3.91	2.87
Cash From Operations, 5 Yr. CAGR %	-7.9	-4.4	-0.11	7.52	-4.61
Capital Expenditures, 5 Yr. CAGR %	10.48	5.65	2.25	8.28	6.78
Levered Free Cash Flow, 5 Yr. CAGR %	-19.62	-28.06	-7.67	8.66	-12.35
Unlevered Free Cash Flow, 5 Yr. CAGR %	-18.25	-22.65	-4.72	7.93	-10.56
Dividend Per Share, 5 Yr. CAGR %	14.87	14.87	14.87	5.92	31.95